Bellevue Asset Management »

Globus Med Inc cl a shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Globus Med Inc cl a (GMED) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Globus Med Inc cl a

Tip: Access up to 7 years of quarterly data

All positions including Globus Med Inc cl a held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Globus Med Inc cl a by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $2.4M 88k 27.82
2015-09-30 $1.8M 88k 20.66
2015-06-30 $2.3M 88k 25.67
2015-03-31 $2.3M 90k 25.24

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Globus Med Inc cl a

Vanguard Group
Henderson Group
Bank of New York Mellon
Wellington Management Company
William Blair Investment Management
Millennium Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Norges Bank Investment Management
Jennifer Ranahan
Marshall Wace
Van Berkom & Associates
Geneva Capital Management
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Globus Med Inc cl a